Download the Free Unbound MEDLINE PubMed App to your smartphone or tablet.
Available for iPhone, iPad, iPod touch, and Android:
Available for Mac and Windows Desktops and laptops:
- Basal buffer systems for a newly glycosylated recombinant human interferon-β with biophysical stability and DoE approaches. [JOURNAL ARTICLE]
- Eur J Pharm Sci 2015 Jul 25.
- Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study. [Journal Article]
- PLoS One 2015; 10(7):e0133279.
- Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond. [REVIEW, JOURNAL ARTICLE]
- Int J Mol Sci 2015; 16(7):16414-16439.
- [Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis]. [English Abstract, Journal Article]
- Rev Neurol 2015 Aug 16; 61(4):145-52.
- The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. [Journal Article, Review]
- Patient Prefer Adherence 2015.:923-42.
- Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study. [Journal Article]
- Int J Mol Sci 2015; 16(7):15271-86.
- Treatment for inclusion body myositis. [Journal Article]
- Cochrane Database Syst Rev 2015.:CD001555.
- Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome. [JOURNAL ARTICLE]
- AJNR Am J Neuroradiol 2015 Jun 25.
- Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. [JOURNAL ARTICLE]
- J Neurol Neurosurg Psychiatry 2015 Jun 25.
- Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study. [Journal Article]
- Expert Opin Drug Deliv 2015 Aug; 12(8):1239-50.